M&T BANK CORP - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 413 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.

Quarter-by-quarter ownership
M&T BANK CORP ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$434,540
+19.7%
3,582
+13.0%
0.00%
+100.0%
Q2 2023$363,158
-11.1%
3,171
+7.0%
0.00%
-50.0%
Q1 2023$408,583
-81.1%
2,963
-84.0%
0.00%
-50.0%
Q4 2022$2,157,717
+188.9%
18,493
+174.2%
0.00%
+33.3%
Q3 2022$747,000
+47.9%
6,745
+0.1%
0.00%
+50.0%
Q2 2022$505,000
-1.4%
6,737
+2.8%
0.00%0.0%
Q1 2022$512,000
-18.3%
6,554
-5.9%
0.00%
-33.3%
Q4 2021$627,000
-0.6%
6,966
+2.1%
0.00%0.0%
Q3 2021$631,000
+21.6%
6,826
+2.2%
0.00%
+50.0%
Q2 2021$519,000
+14.6%
6,680
+10.0%
0.00%0.0%
Q1 2021$453,000
-58.5%
6,073
-5.1%
0.00%
-60.0%
Q4 2020$1,092,000
+6.3%
6,402
-12.5%
0.01%0.0%
Q3 2020$1,027,000
+131.8%
7,318
+164.8%
0.01%
+150.0%
Q2 2020$443,000
+58.8%
2,764
-3.5%
0.00%0.0%
Q1 2020$279,000
-26.0%
2,863
-2.0%
0.00%0.0%
Q4 2019$377,000
+77.0%
2,921
+3.1%
0.00%
+100.0%
Q3 2019$213,000
-33.6%
2,833
+33.9%
0.00%
-50.0%
Q2 2019$321,000
-33.7%
2,116
-47.8%
0.00%
-33.3%
Q1 2019$484,000
+48.9%
4,056
+36.2%
0.00%
+50.0%
Q4 2018$325,000
-30.0%
2,979
+4.0%
0.00%0.0%
Q3 2018$464,000
+101.7%
2,865
-52.0%
0.00%0.0%
Q4 2015$230,000
-5.7%
5,963
-21.5%
0.00%0.0%
Q3 2015$244,000
+10.4%
7,593
-27.7%
0.00%
+100.0%
Q3 2014$221,00010,5000.00%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Casdin Capital, LLC 1,010,330$122,472,20313.56%
Finepoint Capital LP 145,357$17,620,1768.78%
Avoro Capital Advisors LLC 4,025,000$487,910,5007.61%
Saturn V Capital Management LP 118,401$14,352,5696.01%
Ghost Tree Capital, LLC 150,000$18,183,0005.98%
Ikarian Capital, LLC 3,673$44,524,1065.36%
ACUTA CAPITAL PARTNERS, LLC 550$7,580,6505.08%
Eagle Health Investments LP 174,212$21,117,9794.65%
Boxer Capital, LLC 600,000$72,732,0003.87%
GREAT POINT PARTNERS LLC 165,200$20,025,5443.65%
View complete list of SAREPTA THERAPEUTICS INC shareholders